Skip to content
Search

Latest Stories

Despite US nod; EU, UK resist Covid-19 vaccine patent waiver

THE EU, Britain and Japan continued to voice doubts at the World Trade Organization (WTO) on Monday (31) about a proposed intellectual property waiver on Covid-19 products including vaccines, a Geneva trade official said.

Proposals to initiate text-based discussions on an IP waiver, rather than more general talks, gained traction at an informal meeting of the World Trade Organization's Agreement on Trade-Related Aspects of IP Rights (TRIPS) council, the official said.


"The virus has not given us a timeout to go on endlessly discussing the need for or benefit of a waiver. We must rather infuse some certainty in these uncertain times by agreeing to start text-based negotiations on the waiver proposal," India said in the statement.

The United States, China, Ukraine and New Zealand have thrown their weight behind the bid to waive certain TRIPS provisions.

The TRIPS waiver is a necessary, proportionate and temporary legal measure for removing IP barriers and paving the way for more companies to produce Covid-19 vaccines, therapeutics or diagnostics by providing them with the freedom to operate without the fear of infringement of IP rights or the threat of litigation.

"We as co-sponsors of the waiver proposal recognise that IPs are not the only barrier to augmenting manufacturing and addressing supply-side constraints. However, we do believe that IPs are the biggest barrier in addressing supply-side constraints, and thus need to be addressed on priority. The waiver is not sufficient, but rather a necessary element of a multipronged strategy," India also said in the statement.

However, some members "continued to express doubts about the convenience of starting negotiations and asked for more time" to analyse the proposal, the official said.

They included the European Union, Australia, Brazil, Britain, Japan, Norway, Singapore, South Korea, Switzerland and Taiwan.

Agreements at the WTO require the consensus backing of all 164 member states.

India and South Africa came forward with the original idea in October. They have also submitted a revised proposal, which currently has the express support of 63 WTO members.

The new text which they and other backers have circulated says the waiver should apply not only to vaccines, but to treatments, diagnostics, medical devices and protective equipment, along with the material and components needed to produce them.

It also says the waiver should last for "at least three years" from the date it takes effect, following which the WTO's General Council should determine whether it should be prolonged.

Differences on IP importance

The trade official said differences continued on the question of whether, and to what extent, IP protection was holding up the goal of beating the pandemic, and about the use and potential improvement of existing flexibilities within the TRIPS terms.

Questions were also raised on the duration and termination of the proposed waiver, the official said.

The United States said it was open to text-based talks on any proposal that could address the immediate need for increased vaccine production and distribution, the official said.

China said that as the initial proposal had been laid down in October, it was time to move to the next stage, the official added.

Pakistan, Argentina, Bangladesh, Egypt, Indonesia and Kenya were among the countries that expressed the need to start negotiations, said the official.

Meanwhile the EU said the immediate goal should be ramping up production alongside measures such as lifting export restrictions for vaccine ingredients.

Switzerland, also home to major pharmaceutical firms, said WTO members should explore ways to use the flexibilities within TRIPS rather than waiving them altogether, the trade official said.

Proponents argue the temporary removal of IP rights will boost production in developing countries and address the dramatic inequity in access.

However, that notion has long been met with fierce opposition from pharmaceutical giants and their host countries, which insisted patents were not the main roadblocks to scaling up production and warned the move could hamper innovation.

The TRIPS Council will hold a formal meeting on June 8-9.

More than 1.9 billion doses of Covid-19 vaccines have been injected in at least 213 territories around the world, according to an AFP count.

Just 0.3 percent have been administered in the 29 lowest-income countries, home to nine per cent of the world's population.

More For You

Is Shah Rukh Khan planning a £28.5 million pan-India blockbuster with Sukumar

Director Sukumar could reunite with Mythri for a record-breaking project with SRK

Getty Images/ CineJosh

Is Shah Rukh Khan planning a £28.5 million pan-India blockbuster with Sukumar, the director of 'Pushpa'?

Rumours are swirling that Shah Rukh Khan may soon headline India’s most expensive film yet, with a whopping £28.5 million (₹300 crore) offer reportedly on the table. The production house behind the buzz? Mythri Movie Makers, the banner that backed Pushpa and Rangasthalam. If true, this would be SRK’s biggest payday ever.

Mythri Movie Makers eye massive collaboration with SRK for their next big ventureGetty Images

Keep ReadingShow less
Mesmerising Odissi Sandhya at The Bhavan, London

Experience the Vibrant Spirit of odissi in Birmingham

Odissi Dance in Birmingham

Lovers of classical Indian dance and culture will be drawn to a mesmerising evening of performance as Odissi Sandhya takes the spotlight at The Bhavan, London, on Saturday, June 21, 2025. Located at 4A Castletown Road, London W14 9HE, The Bhavan is one of the UK's premier institutions for Indian arts, and the perfect venue to host this celebration of heritage and artistry. The event will be led by the talented dancers of Nritya Alaap, who are renowned for their commitment to preserving and promoting Odissi — one of the eight recognised classical dance forms of India.

Odissi, which originated in the temples of Odisha in eastern India, is celebrated for its lyrical grace, expressive gestures (mudras), and devotional themes rooted in mythology and poetry. Through elegant body movements, dramatic storytelling, and rhythmic footwork, the dancers convey narratives from ancient scriptures and folklore, making the performance both spiritual and artistic.

Keep ReadingShow less
Bryan Johnson

Known for creating the “Don’t Die” project, Johnson has turned his body into a human laboratory

Getty Images

No pizza, no alcohol, no late nights: Bryan Johnson’s strict routine to defy ageing

Bryan Johnson, a 47-year-old tech entrepreneur from California, has become a prominent figure in the global longevity movement, attracting both fascination and criticism for his intense health regime. Known for creating the “Don’t Die” project, Johnson has turned his body into a human laboratory, experimenting with extreme methods to delay ageing and boost long-term health.

From tech success to health obsession

Johnson made headlines in 2013 after selling his company, Braintree, to PayPal for $800 million. Following years of depression and personal upheaval, including leaving the Church of Jesus Christ of Latter-day Saints and divorcing his wife, Johnson redirected his focus to health and longevity.

Keep ReadingShow less
Bangladesh's Muhammad Yunus to step down after April polls

Chief adviser to the government of Bangladesh Professor Muhammed Yunus speaks during a live interview at Chatham House on June 11, 2025 in London, United Kingdom. (Photo by Leon Neal/Getty Images)

Bangladesh's Muhammad Yunus to step down after April polls

BANGLADESH interim leader Muhammad Yunus said on Wednesday (11) that there was "no way" he wanted to continue in power after elections he has announced for April, the first since a mass uprising overthrew the government.

The South Asian nation of around 180 million people has been in political turmoil since a student-led revolt ousted then prime minister Sheikh Hasina in August 2024, ending her 15-year rule.

Keep ReadingShow less